Trial intelligence / Profile preview

Ketorolac vs Triamcinolone Intra-articular Knee Injections for Osteoarthritis

NCT02295189Completed

Sponsor
Brooke Army Medical Center
Start
Jan 2013
Primary completion
May 2014
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of ketorolac in knee osteoarthritis (OA) (2 arms), sponsored by Brooke Army Medical Center. Primary endpoint: Visual Analogue Scale at 6 months. Started Jan 2013; status: completed.

02

Drugs

ketorolac
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02295189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02295189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call